Epidermolysis Bullosa Medical Research Foundation

Analysis

Epidermolysis Bullosa Medical Research Foundation is a registered charity in United States, based in Los Angeles, CA. It received its IRS tax-exemption ruling in March 1996, 30 years ago. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending August 2023, Epidermolysis Bullosa Medical Research Foundation reported income of $1.4m and spending of $346k, leaving 74% of income unspent that year. Across the 5 years on record, from August 2019 to August 2023, income fell from $2.5m to $1.4m (-46%), an average of -14% a year. The sharpest change came in the year to August 2023, when income rose by 247%. Over the whole period it spent 94% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Epidermolysis Bullosa Medical Research Foundation sits at the 81st percentile: it is larger than about 81% of them. Against every charity in United States with reported income it ranks in the 82nd percentile, and in the 83rd percentile within CA. Charities of a similar size with the same main cause include Habitat for Humanity International Inc ($1.4m), DLC Nurse & Learn Inc ($1.4m) and One on One ($1.4m).

On its Form 990 for the period ending August 2023, revenue came from contributions and grants 101% of the total. At year end it held assets of $3.9m against liabilities of $0, net assets of $3.9m.